chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ACUTE RESPIRATORY FAILURE 11/7/2022 HYPERTENSIVE URGENCY  ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/12/2022 HYPERTENSIVE URGENCY  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 HYPERTENSIVE URGENCY  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 HYPERTENSIVE URGENCY  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 HYPERTENSIVE URGENCY  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 HYPERTENSIVE URGENCY  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 HYPERTENSIVE URGENCY  HYPOXIA 12/26/2022 HYPERTENSIVE URGENCY  ACUTE RESPIRATORY FAILURE 11/7/2022 ACHALASIA  ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/12/2022 ACHALASIA  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACHALASIA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 ACHALASIA  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACHALASIA  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 ACHALASIA  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACHALASIA  HYPOXIA 12/26/2022 ACHALASIA  ACUTE RESPIRATORY FAILURE 11/7/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/12/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE  HYPOXIA 12/26/2022 ACUTE HYPERCAPNIC RESPIRATORY FAILURE  ACUTE RESPIRATORY FAILURE 11/7/2022 ACUTE RESPIRATORY FAILURE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/12/2022 ACUTE RESPIRATORY FAILURE  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACUTE RESPIRATORY FAILURE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 ACUTE RESPIRATORY FAILURE  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACUTE RESPIRATORY FAILURE  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 ACUTE RESPIRATORY FAILURE  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 ACUTE RESPIRATORY FAILURE  HYPOXIA 12/26/2022 ACUTE RESPIRATORY FAILURE  ACUTE RESPIRATORY FAILURE 11/7/2022 PULMONARY EDEMA  ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/12/2022 PULMONARY EDEMA  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 PULMONARY EDEMA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 PULMONARY EDEMA  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 PULMONARY EDEMA  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/26/2022 PULMONARY EDEMA  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 12/26/2022 PULMONARY EDEMA  HYPOXIA 12/26/2022 PULMONARY EDEMA
When I woke up my arm was hurting really bad, went to work and started feeling aches, then started getting bad chills, couldn't get warm, headache, then started sweating, temperature is 101.7. Took some advice at 10:00 am, but has not helped.
Pt called to report reaction on 10/19/11. Pt stated reaction occurred 2 hours after administration of the vaccine. Pt stated she felt a tickle in her throat coughing, her throat felt thick, and increased heart rate & blood pressure. Pt went to MD then transferred to ER.
experienced soreness at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th October 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After receiving the vaccine the patient experienced soreness at injection site which resolved after 1 day. For tolerance of 2nd dose of Shingrix, refer case US2020AMR250224. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR250224:same patient (2nd dose)
soreness in her muscles/her neck was becoming sore with some pain in her collarbone area; swollen jelly gland; Soreness in her muscles were worse; This is a spontaneous report received from a contactable consumer (patient herself). A 64-year-old-female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), via an unspecified route of administration on an unspecified date as single dose for COIVD-19 immunization. The patient's medical history endometrial cancer (currently in remission) and COVID-19 (twice - once in May where she was asymptomatic and the second time in Jul where she had "every symptoms but respiratory problems" and was subsequently hospitalized and given steroids). Concomitant medications were not reported. On an unspecified date, after the vaccination, when the patient got home, she noticed that she was getting soreness in her muscles that continued throughout the night and were worse when she woke up the next morning. She then reported that on Saturday she noticed her warm was "very, very" sore and could not even lift it. The previous day, the patient stated that she noticed her neck was becoming sore with some pain in her collarbone area. Upon inspection, she noticed two knots that she describes as feeling like "swollen jelly gland" and "pea size." She stated that they were very tender and if she pressed on them, they hurt. The patient would like to know if these knots could be a side effect of the vaccine. She was concerned about getting the second dose of the vaccine because of these symptoms. Response: Spoke from the Full Emergency Use Authorization (name) Prescribing Information Pfizer-Biontech Covid-19 Vaccine Prescribing Information (LAB-1457-6.0. Revised: 25Feb2021), Section 6 to let her know that 0.3% of clinical trial participants reported lymphadenopathy after their vaccination doses. Also spoke from the Fact Sheet for recipients/caregivers (LAB-1451-3.0. Revised: 25Feb2021) regarding contraindications to receiving a dose of the vaccine and what signs of a severe allergic reaction could include. Referred patient to HCP for further guidance. The patient further stated that she needs to have an MRI done this weekend and would like to know if the swollen lymph nodes she is experiencing after her first dose of the Pfizer BioNTech COVID-19 vaccine will affect the MRI. The outcome of the events was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021318427 for same drug same reporter different patient
pt developed sciatic type pain one day after vaccine, then developed progression of pain down extremity and vesicular rash resembling shingles several days after vaccine given
Pretty red and concerning on Sunday morning/ It has not spread and it has dimmed in redness; Her arm was warm on Saturday; Her arm was tender; Sore to the touch after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sore to the touch after vaccination), FEELING HOT (Her arm was warm on Saturday), TENDERNESS (Her arm was tender) and ERYTHEMA (Pretty red and concerning on Sunday morning/ It has not spread and it has dimmed in redness) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included Mastectomy (Patient previously had a double mastectomy and does not have lymph nodes in her left arm.).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN (Sore to the touch after vaccination) and TENDERNESS (Her arm was tender). On 30-Jan-2021, the patient experienced FEELING HOT (Her arm was warm on Saturday). On 31-Jan-2021, the patient experienced ERYTHEMA (Pretty red and concerning on Sunday morning/ It has not spread and it has dimmed in redness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form and BISABOLOL, CERESIN, PARAFFIN SOFT, PARAFFIN, LIQUID, WOOL ALCOHOLS (AQUAPHOR HEALING) (topical) for Adverse event, at a dose of 1 dosage form. At the time of the report, PAIN (Sore to the touch after vaccination), FEELING HOT (Her arm was warm on Saturday), TENDERNESS (Her arm was tender) and ERYTHEMA (Pretty red and concerning on Sunday morning/ It has not spread and it has dimmed in redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient does not have lymph nodes in her left arm.  No Concomitant medication was received by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Follow up received on 21-APR-2021: contains Non-Significant information.Added reporter contact detail Fax number. On 12-Jul-2021: Follow up received and outcome updated to be Recovered/Resolved
Patient presents to the ED with chief complaint of dizziness, muscle aches, tongue numbness, and throat tightening starting approximately 1 hour after she received her first COVID-19 Pfizer vaccine at ER and Urgent Care.
Information has been received from a registered nurse concerning a 29 year old female client who in June 2001 was vaccinated with varicella vaccine. In June 2001, the pt experienced soreness and "some" pox at the injection site. Additional info has been requested.
After clinic visit, patient had swelling and warmth to Hep A injection site. No systemic symptoms of trouble breathing, facial/tongue swelling, or itching. Given 50 mg Benadryl in clinic, mom will continue to watch at least for 1 hour after injection, then patient to call if having new symptoms.
1 week after vaccination- Sore throat, sinus infection, bronchitis  APPEARS unrelated.  I may have picked it up from other co-workers who had similar symptoms.
tingling in tongue, sore throat and deeper voice, heaviness in chest took diphenhydramine tablet, also took prednisone she is prescribed
PATIENT IS EXPERIENCING CHILLS AND FEVER MORE THAN 24 HOURS AFTER INJECTION, PATIENT REPORTED THAT ARM EXTREMELY SORE AND CANNOT RAISE PAST SHOULDER
Deep aching and burning pain in muscle area of left arm when raising or moving arm in any direction, unable to fully raise arm straight up, out and up or towards back. The information sheet given to me when I received the vaccine says it may last many months. To me 10 months is long enough. Please advise how much longer I will have this problem. I have had tetanus shots before, no problem. This is my last for sure.
Pain at the site, extreme swelling at site, headache, nausea, diarrhea, pain under right arm in armpit lymph nodes with swelling on the 11th day.
The following is what I sent to doctor: I sent the following to cardiology Sunday night and received an answered Monday night. I have yet to receive any communications whatsoever namely an appt for this covid test.  I woke up Friday morning with my left shoulder which had arthroscopy in June was hurting excruciatingly. I thought maybe it was slept on it wrong. Now not so sure. The pain lasted all day and I had taken prescribed doses of Tramdol(50mg). About 6:45 Saturday morning I was writhing in pain i never felt this bad before. I was waffling back and forth sweating profusely and freezingly cold. My heart was pounding so very fast and rapid crazy beats. Not only my shoulder in pain but now the tips of my fingers became numb. Believe me i was wishing it would end and I would just maybe die. Labored breathing also mixed with a whole lot of Panic. I took a metropolol ASAP and put a nitro under my tongue. It took just a minute to subside. Pain was gone and no numbness but I was freezing. Took about 20 minutes and 3 blankets before feeling warm again and ok. Fell back to sleep and felt groggy but OK about a hour and a half later. Did not want to call emergency, thinking this is just a passing episode and on the weekends the Doctors are steretypically on the golf course. Will not hesitate calling 911 if this happens again before seeing you hopefully first of Nov 16 week. I just took my BP (10:00 pm Saturday) and was 111/50 with a rather high pulse of 74.   Your symptoms do not fit well with heart symptoms. Pain which lasts all day would not be heart attack pain. Fever and chills suggest infection, not heart disease. Your response to medications also does not fit with heart symptoms. Metoprolol would not even have been absorbed in your stomach within 1 minute. Nitroglycerin generally does not work within 1 minute either. We must exclude infection, particularly COVID. I have ordered COVID testing. You will be called to schedule this within the next 1-2 days. Follow up as planned, but GO TO THE ER IMMEDIATELY if this recurs.
I had headache, muscle fatigue, nausea, stomach pain, severe joint pain in the shoulder where I received the injection. I got Covid tested yesterday afternoon to be safe and I'm waiting on the results.
Patient had rash appear a week or two after receiving 2nd shot of Moderna Covid-19.  Mostly on forearm.  Itchy red welts not pustules.
Moderna COVID-19 Vaccine  Eight days after injection I developed an itchy, red, raised area (like a single large hive) below the injection site. It was sore to the touch and hot. I did not run a fever.  The following day it was no longer raised, but was still itchy and warm rather than hot.  It was no longer tender but had become hard. The next the site was only red and by afternoon it was gone. I did not treat it except to apply a cool compress to alleviate the itching.
left sided mild case of trigeminal neuritis that persisted beyond 48 hrs after vaccination given (symptom-numbness); headache; gritty/sandy sensation in mouth; borderline intermittent scratchy/sore throat, gritty/sandy sensation in mouth; borderline intermittent scratchy/sore throat; lost taste; burning/tingling on tongue; burning/tingling on tongue; This is a spontaneous report from a contactable physician, the patient. A 38-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Number EK5730), intramuscular in the left arm on 28Dec2020 at 12:30 (at the age of 38-years-old) as a single dose for Covid-19 vaccination. edical history included trigeminal neuritis in the past twice, first from herpes simplex virus (HSV1) and second from flu shot a few years ago; acne and recurrent oral HSV 1, all from an unknown date and unknown if ongoing. The patient was allergic to sulfa. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. The patient's concomitant medications included drospirenone, ethinylestradiol (LORYNA) for OCP; prednisone (MANUFACTURER UNKNOWN), short course completed prior to vaccination; beclometasone dipropionate (QNASL); xylometazonline hychrochloride (SUDAFED) which was stopped before vaccination; valaciclovir hydrochloride (VALTREX); ascorbic acid (VITAMIN C) which was stopped before vaccination and multivitamins. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Dec2020 at 12:45, the patient experienced left sided mild case of trigeminal neuritis that persisted beyond 48 hours with symptoms of numbness with decreased sensation on lateral part of V2 trigeminal nerve which started 10-15 mins after vaccination with small spot corner of mouth on left and involved lateral part of entire left side of face from corner of left eye down within 1-2 hours after received vaccine. The patient also experienced headache, borderline intermittent scratchy/sore throat, gritty/sandy sensation in mouth, at 12-14 hours after getting vaccine on 28Dec2020; got burning/tingling on tongue and then lost taste 100% for about 1 hour then started to slightly come back-and waxed and waned until later that evening and most was back to normal except sweet taste still gone. The events resulted in a doctor or other healthcare professional office visit. Therapeutic measures were taken for all of the events which included antihistamines and valaciclovir; and for the trigeminal neuritis only, methylprednisolone pack. The clinical outcome of the event trigeminal neuritis was recovering (lasted longer than 48 hours after vaccination); for headache, stomatitis, throat irritation, oropharyngeal pain, ageusia, tongue discomfort and paraesthesia oral was recovered (at 48 hours after vaccination).
Bacterial meningitis; This serious case was reported by a nurse via sales rep and described the occurrence of bacterial meningitis in a 5-month-old patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   On an unknown date, the patient received Pediarix. On an unknown date, 4 days after receiving Pediarix, the patient experienced bacterial meningitis (Verbatim: Bacterial meningitis) (serious criteria GSK medically significant). The outcome of the bacterial meningitis was unknown.   It was unknown if the reporter considered the bacterial meningitis to be related to Pediarix and Pediarix Pre-Filled Syringe Device.     It was unknown if the company considered the bacterial meningitis to be related to Pediarix and Pediarix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 02-JUN-2023 The nurse reported that a friend had a child that contracted bacterial meningitis 4 days after receiving a dose of Pediarix.  They gave the information which identified the nurse. The reporter consented to follow up.
Patient given immunization in Right arm.  After waiting 16 minutes, as she was leaving facility patient had a vaso vagal response and fell to the floor .  Nurse made comfortable on floor and lifted legs above heart level;  provided cold pack at base of neck and pillow underneath head.  Vital signs taken.  BP  102/68, SPO2 97percent RA, HR  71 .  vital signs stable.  After laying down for 10 minutes patient sat up in chair and stated she felt fine.  Provided patient with juice and crackers. After 10 more minutes patient escorted out of facility with parent.
get the terrible like extremally headache worse then anything I know I used to have it; At about 36 hours I was not able to keep anything down and then I spent whole day l ke vomiting; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (get the terrible like extremally headache worse then anything I know I used to have it) and VOMITING (At about 36 hours I was not able to keep anything down and then I spent whole day l ke vomiting) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product FAMTOZINAMERAN, TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/5)) for an unknown indication.    No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of FAMTOZINAMERAN, TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (get the terrible like extremally headache worse then anything I know I used to have it) and VOMITING (At about 36 hours I was not able to keep anything down and then I spent whole day l ke vomiting). At the time of the report, HEADACHE (get the terrible like extremally headache worse then anything I know I used to have it) and VOMITING (At about 36 hours I was not able to keep anything down and then I spent whole day l ke vomiting) outcome was unknown.            Concomitant medications were not reported.  Patient had the initial series in 2021 got Modema and had absolutely terrible time with the second Modema shot (Unspecified Shot) and patient didn't get booster until now . Patient was told that Pfizer has a lower  dose so tried that. Patient had exactly same of course which previously had with Moderna and was slightly milder. But it was still really awful. So, patient was like most people who got no symptoms and discomfort for about a day and they are okay, patient had three days of hell. About 36 hours were really bad for patient.  Treatment information was not reported.
May 14 at clinic, patient reported severe edema and bruising in bilateral legs the evening of her vaccine. She reported having to miss work for several days. It resolved after several days to a week. Advised patient not to get vaccine at clinic and follow-up with MD treating anemia.
chills/freezing cold; pain in left arm pit; Left arm pit is slightly swollen; feverish; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): US-PFIZER INC-202101814636 (Pfizer).  A 16 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 16Dec2021 14:00 (Lot number: FL3197) at the age of 16 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Yes - allergic to certain tree nuts: allergy to legumes" (unspecified if ongoing), notes: Yes - allergic to certain tree nuts. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EP6955, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 16Jun2021, when the patient was 16 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EP6955, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 26May2021, when the patient was 16 years old, for COVID-19 Immunization. The following information was reported: HEADACHE (non-serious) with onset 16Dec2021 22:00, outcome "recovered" (17Dec2021 11:00), described as "Headache"; PYREXIA (non-serious) with onset 17Dec2021 02:30, outcome "recovered" (17Dec2021 11:00), described as "feverish"; CHILLS (non-serious) with onset 17Dec2021 09:30, outcome "recovered" (17Dec2021 11:00), described as "chills/freezing cold"; AXILLARY PAIN (non-serious) with onset 17Dec2021 02:30, outcome "not recovered", described as "pain in left arm pit"; LYMPHADENOPATHY (non-serious) with onset 17Dec2021 02:30, outcome "not recovered", described as "Left arm pit is slightly swollen". Therapeutic measures were not taken as a result of headache, pyrexia, chills, axillary pain, lymphadenopathy.  Clinical course: Headache starting at 10 pm on 16Dec2021; then feverish; at 2:30 am on 17Dec2021 chills/freezing cold, headache; at 9:30am on 17Dec2021 chills, feverish, headache; At 11am on 17Dec2021 felt fine and no more symptoms. Adverse event start date: 16Dec2021 at 10:00 PM. If covid prior vaccination: No. If covid tested post vaccination: No. Additional symptom of pain in left arm pit which started 2:30am on 17Dec2021 and has not resolved. Left arm pit is slightly swollen. This symptom was not previously reported. Adverse event start date: 17Dec2021, Adverse event start time: 02:30 PM.  Additional information: The patient received no other vaccines within 4 weeks prior to the COVID vaccine. The patient received no other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Known allergies: Allergy to some tree nuts  Follow-up attempts are completed. No further information is expected.